Use of Wearable, Mobile, and Sensor Technology in Cancer Clinical Trials
Open accessThe DOI matches its Crossref record; 8 of the 8 references it cites were found in a registry or an index.
Abstract
As the availability and sophistication of mobile health (mHealth) technology (wearables, mobile technology, and sensors) continues to increase, there is great promise that these tools will be transformative for clinical trials and drug development. This review provides an overview of the current landscape of potential measurement options, including the various types of data collected, methods/tools for collecting them, and a crosswalk of available options. The opportunities and potential drawbacks of mHealth in cancer clinical trials are discussed. Specific concerns related to data accuracy, provenance, and regulatory issues are highlighted, with suggestions for how to address these in future research. Next steps for establishing mHealth methods and tools as legitimate and accepted measures in oncology clinical trials include continuation of regulatory definition by the FDA; establishment of security standards and protocols; refinement and implementation of methods to establish and document data accuracy; and finally, creation of feedback loops wherein regulators receive updates from researchers with better and more timely data, which should decrease trial times and lessen drug development costs. Implementing mHealth technologies into cancer clinical trials has the potential to transform and propel oncology drug development and precision medicine to keep pace with the rapidly increasing developments in genomics and immunology.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Innovation in the pharmaceutical industry: New estimates of R&D costs
DiMasi, J. A., Grabowski, H. G., & Hansen, R. W. (2016) · Journal of Health Economics · doi:10.1016/j.jhealeco.2016.01.012 · Cited by 3,359
Systematic review of the validity and reliability of consumer-wearable activity trackers
Evenson, K. R., Goto, M. M., & Furberg, R. D. (2015) · International Journal of Behavioral Nutrition and Physical Activity · doi:10.1186/s12966-015-0314-1 · Cited by 1,232
Age Group Comparability of Raw Accelerometer Output from Wrist- and Hip-Worn Monitors
HILDEBRAND, M., VAN HEES, V. T., HANSEN, B. H., & EKELUND, U. (2014) · Medicine & Science in Sports & Exercise · doi:10.1249/mss.0000000000000289 · Cited by 1,043
Accuracy of Smartphone Applications and Wearable Devices for Tracking Physical Activity Data
Case, M. A., Burwick, H. A., Volpp, K. G., & Patel, M. S. (2015) · JAMA · doi:10.1001/jama.2014.17841 · Cited by 694
The Performance and Usability of a Factory-Calibrated Flash Glucose Monitoring System
Bailey, T., Bode, B. W., Christiansen, M. P., Klaff, L. J., & Alva, S. (2015) · Diabetes Technology & Therapeutics · doi:10.1089/dia.2014.0378 · Cited by 685
Validity of Consumer-Based Physical Activity Monitors
LEE, J.-M., KIM, Y., & WELK, G. J. (2014) · Medicine & Science in Sports & Exercise · doi:10.1249/mss.0000000000000287 · Cited by 401
Labovitz, D. L., Shafner, L., Reyes Gil, M., Virmani, D., & Hanina, A. (2017) · Stroke · doi:10.1161/strokeaha.116.016281 · Cited by 311
Delivery of Patient-Reported Outcome Instruments by Automated Mobile Phone Text Messaging
Anthony, C. A., Lawler, E. A., Glass, N. A., McDonald, K., & Shah, A. S. (2017) · HAND · doi:10.1177/1558944716672201 · Cited by 22
Cited by
Harnessing consumer smartphone and wearable sensors for clinical cancer research
Low, C. A. (2020) · npj Digital Medicine · doi:10.1038/s41746-020-00351-x · Cited by 120
The Use of Wearables in Clinical Trials During Cancer Treatment: Systematic Review
Beauchamp, U. L., Pappot, H., & Holländer-Mieritz, C. (2020) · JMIR mHealth and uHealth · doi:10.2196/22006 · Cited by 110
Natural Language Processing to Ascertain Cancer Outcomes from Medical Oncologist Notes
Kehl, K. L., Xu, W., Lepisto, E., Elmarakeby, H., Hassett, M. J., Van Allen, E. M., Johnson, B. E., & Schrag, D. (2020) · JCO Clinical Cancer Informatics · doi:10.1200/cci.20.00020 · Cited by 90
Patients' perspective on digital technologies in advanced genitourinary cancers
Rodler, S., Buchner, A., Stief, C. G., Heinemann, V., Staehler, M., & Casuscelli, J. (2021) · Clinical Genitourinary Cancer · doi:10.1016/j.clgc.2020.03.018 · Cited by 27
Metadata
- Authors
- Cox, S. M., Lane, A., & Volchenboum, S. L.
- Venue
- JCO Clinical Cancer Informatics
- Published
- 2018-12
- Volume
- 2
- Issue
- 2
- Pages
- 1-11
- ISSN
- 2473-4276 (ISSN-L)
- OpenAlex
- W2810240533
- Cited by
- 85
- References
- 8
- FWCI
- 14.65
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Use of Wearable, Mobile, and Sensor Technology in Cancer Clinical Trials. https://app.cochat.ai/papers/10.1200/cci.17.00147
- The paper
- Cox, S. M., Lane, A., & Volchenboum, S. L. (2018). Use of Wearable, Mobile, and Sensor Technology in Cancer Clinical Trials. JCO Clinical Cancer Informatics. https://doi.org/10.1200/cci.17.00147
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.